Concepedia

Wolfgang Sippl

WS

Statistics

Publications

208

Citations

10.4K

H-Index

55

Active since

1995

Affiliations

Martin Luther University Halle-Wittenberg(Current)

University of Freiburg

Centre National de la Recherche Scientifique

Inserm

Université de Strasbourg

Wolfgang Sippl is an author at Martin Luther University Halle-Wittenberg specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

1995–2025

208

Publications

208

Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT

Patrice Dubreuil, Sébastien Letard, Marco A. Ciufolini et al. · PLoS ONE · 2009 · 412 citations · Full text

, , +15

Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells

Frédéric Colland, Étienne Formstecher, Xavier Jacq et al. · Molecular Cancer Therapeutics · 2009 · 320 citations · Full text

, , +13

Selective Sirt2 inhibition by ligand-induced rearrangement of the active site

Tobias Rumpf, Matthias Schiedel, Berin Karaman et al. · Nature Communications · 2015 · 299 citations · Full text

, , +7

Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)

Matthias Schiedel, Daniel Herp, Sören Hammelmann et al. · Journal of Medicinal Chemistry · 2017 · 269 citations · Full text

, , +15

Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme

Céline Reverdy, Susan Conrath, Roman Lopez et al. · Chemistry & Biology · 2012 · 267 citations

, , +14

1–5 of 208